Peri-operative and Post-operative Management of Patients with Crohn’s Disease and Ulcerative Colitis.
Clin Gastroenterol Hepatol. 2019 Oct 04;:
Authors: Barnes EL, Lightner AL, Regueiro M
Although the number of available therapies for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD) continues to expand, a significant portion of patients with inflammatory bowel disease (IBD) will require surgical intervention. Surgery remains an integral part of the treatment algorithm for patients with UC and CD, and thus multidisciplinary approaches to the perioperative and postoperative management of patients with IBD are critical to improving outcomes during these periods. New mechanisms of biologic therapies are emerging and new treatment strategies focused on earlier and potentially more aggressive use of immunosuppressive therapies are advocated in the current treatment era. In this review, we outline multidisciplinary strategies for the preoperative management of immunosuppressive therapies, including a discussion of the most recent evidence regarding the safety of biologic therapy in the preoperative period. We also discuss the postoperative medical management of patients undergoing intestinal resection for CD, with a particular focus on risk stratification and appropriate therapy selection in the immediate postoperative setting. Finally, we review potential postoperative complications following restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) and their management.
PMID: 31589972 [PubMed – as supplied by publisher]